Introduction
A healthy immune system relies on the steady production of lymphocytes—small, important cells that defend the body by fighting off infections and even preventing cancer. When their count is threatened, the body feels it. A reduction in their number can lead to recurring illnesses, fatigue, and even serious complications, such as immune failure. One cause for this is bone marrow suppression—a condition where the bone marrow, responsible for producing lymphocyte cells, is suppressed. This article helps you understand the importance of these tiny cells and how a suppressed bone marrow can affect immune function.
What is Bone Marrow, and What Does It Do?
Bone marrow is a semi-solid, spongy tissue located within the hollow parts of bones. It exists in two forms:
Red marrow
It is mostly found in the central skeleton, like the pelvis, skull, spine, shoulder blades, and the ends of long bones like the thigh bone (femur). It is responsible for producing blood cells, including red blood cells, white blood cells, and platelets.1
Yellow marrow
It consists mostly of adipose (fat) tissue. It serves as a fat storage site and is considered haematopoietically inactive (not responsible for blood cell production). Yellow marrow is more common in individuals because, with age, red marrow is gradually replaced by yellow marrow as the demand for active blood cell production decreases and fat storage increases. However, under certain conditions, like severe blood loss, yellow marrow can convert back to red marrow to support blood cell production.1
In adults, red marrow is mainly located in the central bones of the body (such as the spine and pelvis), while yellow marrow fills the remaining spaces in other bones.1
Its Importance in Immune Function
Bone marrow plays a vital role in immune function, particularly in the development of lymphocytes, which are part of the body's adaptive immunity. It contains haematopoietic stem cells, which have the unique ability to develop into various blood cells, including those of the immune system.
Some of these stem cells follow a pathway known as the lymphoid lineage, producing:
B cells
B cells mature in the bone marrow and are responsible for producing antibodies (proteins that bind to harmful invaders to neutralise them). When they encounter a matching antigen (a foreign substance, like a virus or bacterial toxin), they transform into plasma cells and release antibodies that neutralise or tag the invader for destruction. Some become memory B cells, which help the body to rapidly respond if the same threat returns.1
T cells
These cells mature in the thymus (a small organ located behind the breastbone) and focus on threats inside the body’s own cells, such as viruses or cancer. Helper T cells are responsible for facilitating the immune response, while cytotoxic T cells destroy infected or abnormal cells directly. T cells are highly specific and central to cell-mediated immunity (a type of immune response that doesn’t involve antibodies but relies on direct cell-to-cell action).1
Natural Killer cells
Natural killer cells act faster and need prior exposure to invaders. They scan for abnormal cells, like virus-infected or cancerous cells, and kill them on sight. Though part of the innate immune system (the body’s first line of general defence), they arise from the same bone marrow lineage and provide an important early response.1
Understanding Lymphopenia
Lymphopenia (also called lymphocytopenia) is a condition marked by abnormally low levels of lymphocytes in the blood. It is typically defined by an absolute lymphocyte count of less than 1,000 cells per microlitre in adults. In children, the threshold is usually higher (less than 3,000 cells).
Lymphopenia can be a significant indicator of immune system dysfunction and is considered a hallmark feature of both primary (inherited) and acquired immunodeficiency syndromes. It occurs in these conditions:
- Aplastic anaemia, where the bone marrow fails to produce enough blood cells
- Severe protein-calorie malnutrition
- Zinc deficiency, which impairs immune cell development
- HIV/AIDS and other chronic infections
- Autoimmune disorders and some cancers
It may also appear as a side effect of chemotherapy, radiation therapy, or immunosuppressive drugs.
Since lymphocytes are essential for fighting infections, individuals with lymphopenia may be more susceptible to recurrent or severe infections, especially viral and fungal types.2
How is Lymphopenia Diagnosed?
Lymphopenia is diagnosed through a complete blood count (CBC) with differential, which measures the number of lymphocytes, along with red blood cells, platelets, and other white blood cells.
To investigate further, doctors may use flow cytometry, a specialised test that identifies the levels of different lymphocyte types, including T cells, B cells, and NK cells. This helps determine the possible cause of the low count.
In some cases, immunoglobulin tests are done to assess antibody levels. Low levels may suggest that B cells are either reduced or present but not functioning properly.
Additional tests may be used to rule out underlying infections (such as HIV, COVID-19, or tuberculosis) or immune and blood disorders. In certain situations, a bone marrow biopsy or lymph node examination may be required.3
How Bone Marrow Suppression Leads to Lymphopenia
To understand how bone marrow suppression leads to lymphopenia, it helps to know what goes on inside the bone marrow. Haematopoietic stem cells (HSCs) are important in making blood cells. These stem cells are found in the bone marrow and respond to signals from the bone marrow microenvironment by increasing in number and developing into specialised cells, eventually leading to blood cell production. This is a carefully balanced process that ensures immune cells are readily available and ready to respond.4
However, in cases where the bone marrow is suppressed, such as during cancer treatments, certain infections, or autoimmune conditions, the haematopoietic stem cells are either damaged or their function is inhibited. This disruption affects the production of all blood cells, including lymphocytes, leading to a reduction in their numbers and increasing the risk of lymphopenia.5
Causes of Bone Marrow Suppression
Chemotherapy and Radiation
In managing cancers, especially solid tumours, chemotherapy has been a major breakthrough. Drugs like 5-fluorouracil and cisplatin are powerful agents that can kill tumours and stubborn metastatic cancer cells, particularly when the body's natural defences, like natural killer cells and T lymphocytes, have been overwhelmed.5
However, these drugs do not come without their challenges. While targeting cancer cells, they also affect healthy cells, including those in the bone marrow. Chemotherapy can damage the network of small blood vessels in the bone marrow (its vasculature) and harm the delicate structure that supports blood cell production. The bone marrow is highly sensitive to cell cycle-dependent cytotoxic drugs, which is why bone marrow suppression is one of the most common side effects that limits how much of these drugs doctors can safely give.5
Radiation cannot be overlooked. Exposure to radiation can severely damage both the bone marrow's blood supply and the surrounding bone tissue. This leads to injury of haematopoietic stem cells and progenitor cells, which are responsible for producing new blood and immune cells. As a result, the body becomes immunosuppressed.5
Because lymphocytes are among the cells affected, and they play a key role in controlling tumour growth, their reduction can complicate treatment. In some cases, doctors may need to pause cancer therapy and treat the resulting lymphopenia. This adds another layer of difficulty to cancer management.5
Infections
Some infections do not just attack the immune system; they go straight for the bone marrow and interfere with blood cell production. HIV is one of them. Beyond destroying CD4+ T cells, it affects the bone marrow niche (the environment that supports stem cells). It releases viral proteins that damage the cells responsible for helping those stem cells grow and produce lymphocytes.
Parvovirus B19 can also persist in the marrow, infecting developing blood cells. Dengue, caused by a flavivirus, reduces bone marrow cellularity, meaning there are simply fewer cells available. Then there is EBV, which targets B cells and also suppresses bone marrow activity.6,7
Autoimmune Disorders
Autoimmune disorders, like aplastic anaemia, can lead to bone marrow suppression by targeting the body’s own stem cells. In this case, the immune system mistakenly attacks haematopoietic stem and progenitor cells (HSPCs), which are responsible for producing new blood and immune cells.
The attack happens in two main ways:
Direct killing
Activated T cells release cytotoxic (cell-killing) molecules like perforin, which create tiny holes in the surface of bone marrow stem cells. Through these holes, granzyme B enters the cells and causes them to self-destruct.
Indirect inhibition
Instead of killing the stem cells directly, the immune system sends out chemical signals (like interferon-γ and TNF-α) that make it hard for the stem cells to grow or survive. These signals cause stress inside the cells and can lead them to stop working or die off gradually.
These molecules are helpful when fighting infections or cancer, but in autoimmune disorders, they mistakenly target healthy stem cells in the bone marrow.8
Symptoms and Effects of Lymphopenia
Lymphopenia by itself may not cause symptoms at first. Many people don’t feel anything until the immune system becomes too weak to protect the body properly. However, some signs may point to an underlying problem, especially if the lymphopenia is long-term.
Possible signs include:9
- Frequent or unusual infections – like repeated colds, pneumonia, or infections caused by rare organisms such as Pneumocystis jirovecii or cytomegalovirus, which can become severe or even life-threatening
- Delayed healing – cuts, wounds, and illnesses may take longer to clear
- Tiredness and weakness – feeling unusually tired even without stress
- Pale skin, mouth ulcers, or small red spots (petechiae) may point to a blood-related condition
- Skin changes – such as hair loss (alopecia), eczema, or warts
- Enlarged lymph nodes or spleen – may be seen in infections like HIV or conditions like lymphoma
Lymphopenia also increases the risk of developing certain cancers and autoimmune diseases, since the immune system is less able to detect abnormal cells.9
Management and Treatment
Treatment of lymphopenia caused by bone marrow suppression starts by addressing the underlying cause. If chemotherapy is responsible, doctors may reduce the dose or pause treatment temporarily to allow the bone marrow to recover. Medication adjustments, immune-boosting therapies such as immunoglobulin replacement, or haematopoietic growth factors (e.g., filgrastim) may be used. In severe or prolonged cases, a bone marrow transplant may be considered. Nutritional support and infection prevention are also vital. Underlying infections or autoimmune disorders must be properly managed. Regular monitoring helps guide recovery and reduce complications. It is important to consult a healthcare provider for tailored medical advice.10
FAQs
Can bone marrow suppression recover?
Yes, especially if it's temporary or treatment-related. Recovery depends on the cause.
Is lymphopenia dangerous?
It can be. Mild cases may resolve, but severe or prolonged ones increase infection risk.
Summary
Bone marrow plays a very important role in immune defence by producing lymphocytes, which help the body fight infections. When bone marrow is suppressed, such as during chemotherapy, radiation, certain infections, or autoimmune diseases, lymphocyte levels can drop. This condition is known as lymphopenia and weakens the immune system. People may experience frequent infections, slow healing, or constant tiredness. Treatment involves managing the cause, supporting immunity, and using bone marrow stimulants or transplants if needed. Regular medical check-ups are helpful. It is important to consult a healthcare provider if symptoms suggest the immune system is not functioning well.
References
- Rizk SH. Bone Marrow Lymphocytes’ Development and Dynamics [Internet]. www.intechopen.com. IntechOpen; 2023. Available from: https://www.intechopen.com/chapters/1161779
- Faramarz Naeim, P Nagesh Rao, Grody WW. Hematopathology : Morphology, Immunophenotype, Cytogenetics, and Molecular Approaches. Elsevier Science; 2009. Available from: https://books.google.com/books/about/Hematopathology.html?id=BbVm4oyTOGMC
- Berezné A, Bono W, Guillevin L, Mouthon L. Orientation diagnostique devant une lymphopénie. Presse Med [Internet]. 2006 [cited 2025 Nov 21]; 35(5):895–902. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7135154/.
- Kwon M, Kim BS, Yoon S, Oh SO, Lee D. Hematopoietic Stem Cells and Their Niche in Bone Marrow. International journal of molecular sciences [Internet]. 2024 Spring;25(13):6837. Available from: https://pubmed.ncbi.nlm.nih.gov/38999948/
- Hu A, Chen H, Liang J, Liu C, Li F, Mu C. Cell-based therapeutics for the treatment of hematologic diseases inside the bone marrow. Journal of Controlled Release [Internet]. 2021 Nov 10;339:1–13. Available from: https://www.sciencedirect.com/science/article/pii/S0168365921004971
- Candice Lee Herd, Mellet J, Tsungai Mashingaidze, Chrisna Durandt, Michael Sean Pepper. Consequences of HIV infection in the bone marrow niche. Frontiers in Immunology. 2023 Jul 11;14. Available from: https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1163012/full
- Rosenfeld SJ, Young NS. Viruses and bone marrow failure. Blood Reviews. 1991 Jun;5(2):71–7. Available from: https://pubmed.ncbi.nlm.nih.gov/1655129/
- Giudice V, Selleri C. Aplastic anemia: Pathophysiology. Seminars in Hematology. 2022 Jan;59(1). Available from: https://pubmed.ncbi.nlm.nih.gov/35491054/
- Dale DC. Lymphocytopenia [Internet]. MSD Manual Professional Edition. MSD Manuals; 2023. Available from: https://www.msdmanuals.com/professional/hematology-and-oncology/leukopenias/lymphocytopenia#Etiology_v970788
- Hilmas E, Hilmas CJ. Medical Management of Chemical Toxicity in Pediatrics. Academic Press; 2009. p. 919–50. Available from: https://www.sciencedirect.com/science/article/abs/pii/B9780123744845000614

